Francois-Xavier Piloquet
Overview
Explore the profile of Francois-Xavier Piloquet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dupoiron D, Bienfait F, Seegers V, Piloquet F, Pluchon Y, Pechard M, et al.
Cancers (Basel)
. 2025 Jan;
17(2).
PMID: 39858095
CAPTRANE evaluated the efficacy and tolerability of high-concentration capsaicin patch (HCCP) vs. oral pregabalin for the treatment of postsurgical neuropathic pain (PSNP) following breast cancer surgery. The study was designed...
2.
Lemaire A, Pointreau Y, Narciso B, Piloquet F, Braniste V, Sabate J
Support Care Cancer
. 2021 Aug;
29(12):7587-7589.
PMID: 34387729
No abstract available.
3.
Lemaire A, Pointreau Y, Narciso B, Piloquet F, Braniste V, Sabate J
Support Care Cancer
. 2021 Jun;
29(12):7577-7586.
PMID: 34120247
Purpose: Naloxegol, an oral once-daily peripherally acting mu-opioid receptor antagonist, is indicated for the treatment of opioid-induced constipation (OIC) with inadequate response to laxative(s), in cancer and non-cancer patients. This...
4.
Gegu M, Chevalet P, Piloquet F, Berrut G, de Decker L
Geriatr Psychol Neuropsychiatr Vieil
. 2014 Jan;
11(1 Suppl):4-9.
PMID: 24463058
Treatment with vitamin K antagonists are subject to a common iatrogenic mainly characterized by hemorrhagic stroke. Their narrow therapeutic range associated with variability largely explains this phenomenon. New oral anticoagulants...